Healthcare Market Research: Flu Vaccine Uptake Insights

1
Healthcare Market Research Flu Vaccine Uptake
Insights Artificial intelligence (AI) has become
instrumental in analyzing health behaviors,
enabling a more nuanced understanding of factors
influencing patient decisions and healthcare
provider recommendations. This article discusses
the insights derived from an AI-driven healthcare
market research study on flu vaccine uptake. It
targets both patient attitudes and healthcare
professional (HCP) practices, with the primary
goal of enhancing proactive flu vaccination in
various patient demographics.

• Background
• The healthcare market research study underscores
  a common challenge in flu vaccine
  administration a high drop-out rate among
  patients who are recommended to receive flu
  vaccines annually. Many patients struggle to
  differentiate between the flu and a common cold,
  leading to uncertainty about the need for a flu
  vaccine. Furthermore, patient attitudes toward
  flu vaccines differ across demographics, with
  significant disparities observed between urban
  and rural populations, and among high-risk
  patients, healthy adults, and parents.
• Data Collection and Analysis
• The AI-enabled healthcare research analysis mined
  data from over 6,000 conversations, segmented
  into various patient and HCP categories,
  including
• 5,500 parents
• 1,800 healthy adults
• 600 high-risk patients

2

• 1,000 HCP-vaccine promoters
• 950 HCP-vaccine givers.
• Key Findings Beliefs and Barriers
• The healthcare market research study identified
  that patient and HCP attitudes toward flu
  vaccines were influenced by both acknowledged
  beliefs and prevailing barriers. Most
  participants questioned the efficacy of flu
  vaccines, perceiving them as unnecessary for
  everyone. This belief is more prominent in rural
  areas and among younger healthcare providers,
  particularly in regions where flu vaccination is
  not a part of mandatory health policies.
• Urban vs. Rural Discrepancies
• Urban patients and HCPs While urban healthcare
  providers, especially experienced pediatricians
  and polyclinic-based general practitioners (GPs),
  show a willingness to administer flu vaccines
  based on new evidence, urban patients remain
  skeptical about annual vaccinations, with cost
  and perceived lack of necessity as primary
  barriers.
• Rural patients and HCPs The rural demographic
  reflects a significant challenge in promoting
  flu vaccines, with a high percentage of both
  patients and providers feeling that flu vaccines
  are unnecessary. Cost concerns and limited
  exposure to supporting clinical evidence make
  flu vaccine acceptance particularly difficult in
  these regions.
• Barriers to Flu Vaccine Uptake
• Cost and Non-Recommendation High vaccine costs
  and the absence of panel recommendations are
  major impediments. In rural settings, healthcare
  providers are less likely to recommend vaccines
  unless there is strong patient demand.
• Lack of Awareness There is a substantial gap in
  awareness regarding the need for yearly flu
  vaccination, with misconceptions about the flu
  virus being seasonal or non- threatening.
• Questioning Efficacy Both HCPs and patients have
  doubts regarding the efficacy of flu vaccines,
  which is further complicated by conflicting
  information and limited access to recent
  clinical evidence in support of vaccine efficacy.
• Triggers for Flu Vaccine Use
• Patients who have experienced flu episodes
  themselves or within their family networks are
  more likely to seek vaccination proactively. This
  highlights the role of personal experience and
  peer influence in shaping attitudes toward flu
  vaccines.
• Healthcare Market Research Study
  Segment-Specific Insights
• Based on healthcare market research AI analysis,
  HCPs were segmented to identify the best
  approaches to increase flu vaccine
  recommendations across different patient types.
• 1. Urban Pediatricians and Experienced GPs in
  Polyclinics
• These HCPs are more likely to recommend flu
  vaccines due to exposure to new clinical
  evidence. They cater to children and at-risk
  adults, and the presence of informed parents
  often drives proactive vaccine uptake.

3

• Young Urban GPs and Single-Practice GPs
• For these practitioners, new evidence remains
  crucial in swaying their recommendations.
  However, younger GPs tend to support flu vaccines
  based on personal experience rather than patient
  demand.
• Specialists in Urban and Rural Areas
• Specialists in fields such as diabetes,
  geriatrics, and pulmonology have a lower barrier
  to recommending flu vaccines, given their role in
  managing high-risk patients. They are inclined
  to recommend vaccines to prevent acute health
  episodes, although many still prefer brands like
  Abbott over Sanofi due to perceptions of efficacy
  and brand trust.
• Rural Pediatricians and Young GPs
• This segment has the highest resistance to
  recommending flu vaccines, influenced by a
  strong belief that flu vaccines are unnecessary.
  Younger pediatricians in this group may respond
  positively if motivated by patient demand,
  particularly from parents.
• Some additional information is withheld in the
  interest of confidentiality.
• Recommendations for Increasing Flu Vaccine Uptake
• The healthcare market research study recommends
  distinct strategies for different HCP segments
  to address the identified challenges and increase
  flu vaccine acceptance
• Targeting Urban Pediatricians and Experienced
  Polyclinic GPs for Quick Wins Given their
  openness to new evidence, these practitioners can
  serve as effective conduits for promoting flu
  vaccines in urban areas. By prioritizing
  educational outreach with strong clinical
  evidence and simplifying access to updated
  vaccine information, it is possible to increase
  flu vaccine prescription rates in this group.
• Long-Term Efforts for Rural HCPs
• Rural GPs and pediatricians require a gradual
  shift in perception, supported by sustained
  educational initiatives and cost-reduction
  strategies to overcome the financial barriers.
  This will be an extended process that may benefit
  from partnerships with local health authorities
  to bolster vaccine advocacy.
• Involving Specialists Across Urban and Rural
  Areas
• These healthcare providers are open to flu
  vaccines for high-risk adults and may serve as
  intermediaries in rural settings where vaccine
  acceptance is low. Providing these specialists
  with targeted education about flu vaccine
  efficacy in preventing acute episodes could
  improve their support.
• Decide Faster with AI-Based Healthcare Market
  Research
• The AI-enabled healthcare market research study
  highlights the multifaceted nature of flu
  vaccine hesitancy and acceptance among both
  patients and HCPs. While urban practitioners
  show a readiness to prescribe flu vaccines based
  on emerging evidence, rural areas still face
  significant challenges. A more informed HCP and
  patient community can lead to proactive
  vaccination habits, potentially reducing the
  public health burden of influenza in both urban
  and rural settings.
• Contact us at GrapheneAI to strategize your
  vaccine better with AI-powered healthcare market
  research.